Upcoming IPOs This Week: Dr. Agarwal’s Healthcare IPO to Open From January 29

The primary market is set to witness significant activity starting on January 27. This week, two new initial public offerings (IPOs) will launch in the Indian IPO market. Dr Agarwal’s Healthcare is on the mainboard, and Malpani Pipes is on the SME platform.

The IPO market witnessed the debut of Denta Water and Infra Solutions IPO, which received an attractive response from investors across all categories. As a result, This Denta Water and Infra IPO became the most subscribed issue of CY25, with a subscription rate of 221.5 times.

Main Board IPO

Dr. Agarwal’s Healthcare IPO

The ₹3,027.26 Crore Dr Agarwal’s Healthcare IPO will be open for subscription from January 29 to January 31. The issue includes a fresh issue of 0.75 crore shares worth ₹300 crore and an offer for sale of 6.78 crore shares totalling ₹2,727.26 crore.

The price band for the IPO has been set between ₹382 and ₹402 per share. The lead managers for the issue are Kotak Mahindra Capital Company Limited, Morgan Stanley India Company Pvt Ltd, Jefferies India Private Limited, and Motilal Oswal Investment Advisors Limited. Kfin Technologies Limited will act as the registrar.

SME IPO

Malpani Pipes IPO

The Malpani Pipes IPO will also be open for subscription from January 29 to January 31. The IPO is valued at ₹25.92 crore and consists entirely of a fresh issue of 28.80 lakh shares. The price band for this issue is ₹85 to ₹90 per share. Interactive Financial Services Ltd is the lead manager, Bigshare Services Pvt Ltd will act as the registrar, and Mnm Stock Broking Private Limited is the market maker.

Listing Schedule For This Week

• January 27: CapitalNumbers Infotech IPO on BSE SME
• January 29: Denta Water IPO on BSE and NSE, Rexpro Enterprises IPO on NSE SME
• January 30: CLN Energy IPO on BSE SME
• January 31: GB Logistics IPO and H.M. Electro Mech IPO on BSE SME

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their research and assessments to form an independent opinion about investment decisions.

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.